Aug 11, 2026 08:17AM
Aug 11, 2026 08:15AM
Aug 11, 2026 08:01AM
Aug 11, 2026 08:00AM
Aug 11, 2026 08:00AM
Aug 11, 2026 08:00AM
Jul 8, 2026 07:01AM Aura Biosciences adds former Day One CEO to its board
Jul 8, 2026 07:01AM
May 14, 2026 07:00AM
May 14, 2026 07:00AM
Oct 16, 2023 07:50AM
Dec 13, 2022 08:55AM
Aug 22, 2022 05:43AM
Aug 22, 2022 04:00AM Mereo BioPharma Sends Letter to Rubric Capital Management
Aug 22, 2022 04:00AM
Mar 31, 2022 04:01PM
Mar 31, 2022 04:01PM
Sep 7, 2021 07:35AM
Mar 31, 2021 05:02PM
Mar 31, 2021 05:02PM
Mar 24, 2021 05:00AM Mission Therapeutics Welcomes Co-founder of Rosetta Capital, Jonathan Hepple, to its Board of Directors
Feb 11, 2021 04:05PM
Dec 18, 2020 09:22AM
Sep 29, 2020 07:00AM
Jun 30, 2020 07:00AM
Jun 16, 2020 07:00AM
Mar 27, 2020 08:00AM
Feb 28, 2020 07:08AM Mereo BioPharma (MREO) Reports Positive Feedback from Type B End-of-Ph. 2 Meeting with FDA & Outlines Pivotal Ph. 3 Pediatric Study Design for Setrusumab in Osteogenesis Imperfecta
Feb 28, 2020 07:00AM
Feb 19, 2020 03:00AM
Feb 12, 2020 08:00AM
Feb 10, 2020 07:00AM
Jan 14, 2020 07:03AM
Jan 14, 2020 07:00AM
Jan 13, 2020 07:00AM Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab
Jan 13, 2020 07:00AM
Nov 11, 2019 06:30AM
Oct 7, 2019 08:02AM
Oct 7, 2019 08:00AM
Sep 17, 2019 07:00AM
Sep 10, 2019 08:00AM
Sep 4, 2019 08:00AM Mereo BioPharma Announces Setrusumab 6-Month Phase 2b Data in Osteogenesis Imperfecta Selected for Late-Breaking Oral Presentation at the American Society for Bone and Mineral Research (ASBMR) 2019 An
Jul 16, 2019 08:00AM
Jul 15, 2019 08:06AM
Jul 15, 2019 08:00AM
Jun 13, 2019 08:00AM
May 30, 2019 05:47AM
May 30, 2019 02:00AM
May 3, 2019 12:09PM Mereo BioPharma Group plc (“Mereo” or the “Company” or the “Group”) Intention to Purchase Shares by Trustee of Employee Benefit Trust
Apr 29, 2019 02:00AM

1,180,360 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All